%D9%83%D9%84%D9%88%D8%A8%D9%8A%D8%AF%D9%88%D8%BA%D8%B1%D9%8A%D9%84%DA%A9%D9%84%D9%88%D9%BE%DB%8C%D8%AF%D9%88%D9%82%D8%B1%D9%84ClopidogrelCategory:ClopidogrelClopidogrelClopidogrelClopidogrelClopidogrelClopidogrel%DA%A9%D9%84%D9%88%D9%BE%DB%8C%D8%AF%D9%88%DA%AF%D8%B1%D9%84KlopidogreeliClopidogrelKlopidogr%C3%A9l%D4%BF%D5%AC%D5%B8%D5%BA%D5%AB%D5%A4%D5%B8%D5%A3%D6%80%D5%A5%D5%ACClopidogrel%E3%82%AF%E3%83%AD%E3%83%94%E3%83%89%E3%82%B0%E3%83%AC%E3%83%AB%ED%81%B4%EB%A1%9C%ED%94%BC%EB%8F%84%EA%B7%B8%EB%A0%90Clopidogrelum%E0%B4%95%E0%B5%8D%E0%B4%B2%E0%B5%8B%E0%B4%AA%E0%B5%8D%E0%B4%AA%E0%B4%BF%E0%B4%A1%E0%B5%8B%E0%B4%97%E0%B5%8D%E0%B4%B0%E0%B5%BDClopidogrel%E0%AC%95%E0%AD%8D%E0%AC%B2%E0%AD%8B%E0%AC%AA%E0%AC%BF%E0%AC%A1%E0%AD%8B%E0%AC%97%E0%AD%8D%E0%AC%B0%E0%AD%87%E0%AC%B2KlopidogrelClopidogrelClopidogrel%D0%9A%D0%BB%D0%BE%D0%BF%D0%B8%D0%B4%D0%BE%D0%B3%D1%80%D0%B5%D0%BBKlopidogrelKlopidogrelKlopidogrel%D0%9A%D0%BB%D0%BE%D0%BF%D1%96%D0%B4%D0%BE%D0%B3%D1%80%D0%B5%D0%BB%D1%8CClopidogrelQ410237%E6%B0%AF%E5%90%A1%E6%A0%BC%E9%9B%B7
about
sameAs
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibilityClopidogrel plus aspirin versus aspirin alone for preventing cardiovascular diseaseClopidogrel plus aspirin versus aspirin alone for preventing cardiovascular diseaseClopidogrel and aspirin versus aspirin for preventing cardiovascular disease in those at high riskAdenosin-diphosphate (ADP) receptor antagonists (clopidogrel, ticlopidine) for the prevention of cardiovascular disease in type 2 diabetes mellitusImpact of proton pump inhibitors on efficacy of clopidogrel: Review of evidenceClopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designsEffects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second StrokesAspirin and extended-release dipyridamole versus clopidogrel for recurrent strokeThe drug-drug interaction between proton pump inhibitors and clopidogrelThe active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid raftsResults of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?Is clopidogrel superior to aspirin in secondary prevention of vascular disease?Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrelThe clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423].Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialSwitching from clopidogrel to prasugrel: Efficacy and safety dataClopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-AnalysisGenetic factors influencing efficacy of clopidogrel treatmentPharmacodynamic impacts of proton pump inhibitors on the efficacy of clopidogrel in vivo--a systematic reviewClopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?High residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistanceClopidogrel and proton pump inhibitors--where do we stand in 2012?Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapyHigh-maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisThe gain-of-function variant allele CYP2C19*17: a double-edged sword between thrombosis and bleeding in clopidogrel-treated patientsEffect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trialsClopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysisEffect of clopidogrel with aspirin on functional outcome in TIA or minor stroke: CHANCE substudy.Structures of Cytochrome P450 2B4 Complexed with the Antiplatelet Drugs Ticlopidine and Clopidogrel,X-ray crystal structure of the cytochrome P450 2B4 active site mutant F297A in complex with clopidogrel: Insights into compensatory rearrangements of the binding pocketClopidogrel and hip fractures, is it safe? A systematic review and meta-analysisAspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysisEffects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyA comparison of 1-month and 6-month clopidogrel therapy on clinical and angiographic outcome after stent implantationUrgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapyEffects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) studyThe role of clopidogrel in the management of acute coronary syndromesEffects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trialEffects of statins on platelet inhibition by a high loading dose of clopidogrel
P921
Q1209150-9C12EE4B-3068-48D4-AD58-177072BBB081Q12252367-D6628783-6133-4442-A633-57D92BC3E7F7Q1444550-1d7b408c-4633-141b-a8d2-36bc6b785fdbQ1576205-118DDB6C-2DF9-4F87-9BDF-EAE4C4E8FB0FQ184559-F1F95A32-A9E8-4A5F-B4FC-2F93EA3A3F2FQ18558122-03BFCDB2-367A-4106-A185-7939D9744AFBQ190805-EF374348-AFB6-4F73-8E32-622DEBA5A265Q2032041-3D2C6845-8782-4D66-A92D-190AB16AD514Q261327-E8D812A9-067D-4F03-9CC6-8AD154C4163FQ266018-735012D2-E6F1-4C3E-BCA9-C014B516D685Q593958-CCACA613-C154-4ABD-8DEA-A71F070591E0Q815819-79862A15-607D-4848-931B-4839E3BE60E6
P2176
Q29005611-B5E1CE4B-9F71-48CD-B0E0-2A21D3D2BC49Q29005613-A27CA8FF-6C51-44C0-A949-4E50AB95FB0AQ29005615-EE2065F0-3CB4-4A18-A9CB-9214DD7D63B3Q29005616-501C1376-C871-4F41-A9A5-611C33556A65Q29005624-8C78AD79-B323-4C4C-9B93-8542FC21A423Q29005631-B1FE7724-D260-4950-8297-D29452AB1AFBQ29005634-EC248240-36D0-44C0-BDE8-6D33301E1D48Q29005636-DFD0BAEA-2709-4743-B025-1FE1F84567FBQ29005645-5A314AF6-043E-4802-9301-446BB94AB977Q29006035-30C06B34-311F-41FF-8BB7-E18B6BB15589Q29006343-9955E65A-614D-4C51-AE4D-B45A98E11202
P3781
description
antitrombotico con indicazione ...... o di malattie cardiovascolari.
@it
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Clopidogrel
@da
Clopidogrel
@de
Clopidogrel
@es
Clopidogrel
@it
Clopidogrel
@nl
Clopidogrel
@ro
Clopidogrel
@ur
Clopidogrel
@vi
Clopidogrelum
@la
Klopidogreeli
@fi
type
label
Clopidogrel
@da
Clopidogrel
@de
Clopidogrel
@es
Clopidogrel
@it
Clopidogrel
@nl
Clopidogrel
@ro
Clopidogrel
@ur
Clopidogrel
@vi
Clopidogrelum
@la
Klopidogreeli
@fi
altLabel
(+)-Clopidogrel
@cy
(+)-Clopidogrel
@en
113665-84-2
@fr
ATC kod B01AC04
@sr
ATCvet kod QB01AC04
@sr
Areplex
@pl
C16H16Cl1N1O2S1
@it
C16H16ClNO2S
@fr
C16H16ClNO2S
@sr
Clopidix
@pl
prefLabel
Clopidogrel
@da
Clopidogrel
@de
Clopidogrel
@es
Clopidogrel
@it
Clopidogrel
@nl
Clopidogrel
@ro
Clopidogrel
@ur
Clopidogrel
@vi
Clopidogrelum
@la
Klopidogreeli
@fi